Molecule from worm could lead to new rheumatoid arthritis drugs

09/16/2008 | BBC

Parasitic nematode worms release a molecule called ES-62 that can inhibit inflammatory reactions responsible for certain diseases, Scottish researchers reported. They hope to create a synthetic version of the molecule to develop treatments for rheumatoid arthritis and other auto-immune disorders.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC